Abstract
Introduction To better assess the epidemiological situation of acute respiratory illness in Germany over time, we used emergency department data for syndromic surveillance before and during the COVID-19 pandemic.
Methods We included routine attendance data from emergency departments who continuously transferred data between week 10-2017 and 10-2021, with ICD-10 codes available for >75% of the attendances. Case definitions for acute respiratory illness (ARI), severe ARI (SARI), influenza-like illness (ILI), respiratory syncytial virus disease (RSV) and Coronavirus disease 2019 (COVID-19) were based on a combination of ICD-10 codes, and/or chief complaints, sometimes combined with information on hospitalisation and age.
Results We included 1,372,958 attendances from eight emergency departments. The number of attendances dropped in March 2020, increased during summer, and declined again during the resurge of COVID-19 cases in autumn and winter of 2020/2021. A pattern of seasonality of acute respiratory infections could be observed. By using different case definitions (i.e. for ARI, SARI, ILI, RSV) both the annual influenza seasons in the years 2017-2020 and the dynamics of the COVID-19 pandemic in 2020-2021 were apparent. The absence of a flu season during the fall and winter of 2020/2021 was visible, in parallel to the resurge of COVID-19 cases. The proportion of SARI among ARI cases peaked in April-May 2020 and November 2020-January 2021.
Conclusion Syndromic surveillance using routine emergency department data has the potential to monitor the trends, timing, duration, magnitude and severity of illness caused by respiratory viruses, including both influenza and SARS-CoV-2.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Robert Koch Institute is an Institute within the portfolio of the Federal Ministry of Health. This work was funded by the Innovation Committee of the Federal Joint Committee (Innovationsfonds des Gemeinsamen Bundesausschusses, G-BA) [ESEG project, grant number 01VSF17034]. The implementation and operation of the AKTIN-Emergency Department Data Registry is funded by the Federal Ministry of Education and Research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
In AKTIN and ESEG, individual patient consent is not provided for the context of the emergency situation and the technical and organizational measures provided. The AKTIN-register received medical ethical approval from the Ethics Committee of the Otto von Guericke University Magdeburg, Medical Faculty (160/15). The AKTIN scientific board approved regular/daily data query and transmission to RKI (Project-ID 2019-003). Due to the anonymized nature of the data, an ethical approval was not necessary for ESEG data, as disclosed by the ethics committee of the physicians chamber Hesse. The data were transferred anonymously. The data model uses a minimal set of data points, or categorisation of specific data elements (e.g. age in years and groups, instead of date of birth), which ensures personal data protection, and defines an approved list of variables. The data protection officer of the RKI has approved the use of anonymized case-based emergency department data using the NoKeDa model for research purposes (BDS/ISB, 09-01-2019).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The aggregated data of the attendances and cases (ARI, SARI, ILI, RSV, COVID-19) by week used for the analysis, will be provided.
